uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results

uniQure N.V. (NASDAQ:QURE) is one of the 12 Best Performing Stocks in the Last 3 Months. On October 8, RBC Capital reiterated a Buy rating on uniQure N.V. (NASDAQ:QURE) and increased its price target from $55 to $65.

Moreover, on October 6, H.C. Wainwright also raised its price target on uniQure N.V. (NASDAQ:QURE) from $70 to $110 and kept a Buy rating.

uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results

These updates came after the company reported positive topline data from its Phase I/II study of AMT-130 for treating Huntington’s disease on September 24. The data showed that its gene therapy, AMT-130, slowed down the progression of Huntington’s disease.

According to the report, this pivotal study met the primary endpoint and showed that a high dose of AMT-130 slowed the disease by 75% over 36 months. uniQure N.V. (NASDAQ:QURE) also said that the treatment was generally safe and well-tolerated.

Currently, there are no approved therapies to delay the onset or slow the progression of Huntington’s disease. uniQure N.V.’s (NASDAQ:QURE) AMT-130 could significantly change the treatment landscape for this disease

The FDA has granted AMT-130 a special designation as a Breakthrough Therapy designation and Regenerative Medicine Advanced Therapy (RMAT). uniQure N.V. (NASDAQ:QURE) expects to submit a biologics license application (BLA) in the first quarter of 2026 and plans to launch the treatment in the US later that year after approvals.

uniQure N.V. (NASDAQ:QURE) is a Dutch biotechnology company focused on developing gene therapies for serious diseases.

While we acknowledge the potential of QURE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than QURE and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Best American AI Stocks to Buy According to Analysts and 11 Dirt Cheap Stocks to Buy According to Analysts.

Disclosure: None. This article is originally published at Insider Monkey.